Home | Medical Dictionary | Contact Us         
 
 
  • About
    Cedars-Sinai
  • Careers at
    Cedars-Sinai
  • Giving
    & Support
  • Health
    Conditions
  • Healthcare
    Professionals
  • Patients
    & Visitors
  • Programs
    & Services
  • Quality
    Measures
  • Research &
    Education
  • Programs and Services
  • Samuel Oschin Comprehensive Cancer Institute
  • Advances in Cancer
  • Cancers Treated
  • Centers and Programs
  • Contact Us
  • Events
  • For Patients
  • For Physicians
  • Genetic Screening
  • In the News
  • Inpatient Services
  • Our Expert Team
  • Outpatient Cancer Center
  • Quality Measures & Outcomes
  • Research
  • Blood Cell Development Research
  • Brain Tumor Research
  • Breast Cancer Research
  • Clinical Trials
  • Gene Cloning Research
  • Kaposi's Sarcoma Virus Research
  • Leukemia & Lymphoma Research
  • Non-Hodgkin's Lymphoma Research
  • Ovarian Cancer Research
  • Prostate Cancer Research
  • Stem Cell Biology Research
  • Tumor Suppressor Gene Research
  • Women's Cancer Research Institute
  • Shared Resources
 

Blood Cell Development Research

A gene that controls development of blood cells, known as C/EBPe, has been isolated.

This gene may be one of the master switches that allow white blood cells to develop. When the C/EBPe gene is removed in mice, the animals develop preleukemia and infections because certain proteins are suppressed.

Our researchers have recently identified this gene as the one that is turned on by retinoic acid in the treatment of acute leukemia. Retinoic acid puts these patients into complete remission.

 
Cedars-Sinai Logo

© Copyright 2000-2009 Cedars-Sinai Health System.
All rights reserved.
Privacy Policy Terms and Conditions